StonvexLoading…
StonvexStonvexStonvexCore line items from HURN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $457.99M | $443.71M | $1.66B | $1.23B | $798.20M |
Operating Income | Not available | $36.58M | $178.57M | $128.39M | $78.39M |
Net Income | Not available | $23.25M | $105.04M | $74.39M | $43.97M |
EPS (Diluted) | $2.24 | $1.34 | $5.84 | $4.13 | $2.42 |
Total Assets | Not available | $1.59B | $1.53B | $1.54B | $1.48B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $26.46M | $24.51M | $23.89M | $61.01M |
Free Cash Flow OCF − CapEx | Not available | $-167.85M | $182.96M | $59.13M | $-30.67M |
Shares Outstanding | Not available | 17.41M | 17.99M | 18.02M | 18.14M |